chr17-75847496-T-C

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_012478.4(WBP2):​c.646A>G​(p.Thr216Ala) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

WBP2
NM_012478.4 missense

Scores

3
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.50
Variant links:
Genes affected
WBP2 (HGNC:12738): (WW domain binding protein 2) The globular WW domain is composed of 38 to 40 semiconserved amino acids shared by proteins of diverse functions including structural, regulatory, and signaling proteins. The domain is involved in mediating protein-protein interactions through the binding of polyproline ligands. This gene encodes a WW domain binding protein that is a transcriptional coactivator of estrogen receptor alpha and progesterone receptor. Defects in this gene have been associated with hearing impairment. [provided by RefSeq, Jan 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.19477999).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WBP2NM_012478.4 linkc.646A>G p.Thr216Ala missense_variant Exon 6 of 8 ENST00000254806.8 NP_036610.2
WBP2NM_001348170.1 linkc.646A>G p.Thr216Ala missense_variant Exon 7 of 9 NP_001335099.1
WBP2NM_001330499.2 linkc.511A>G p.Thr171Ala missense_variant Exon 5 of 7 NP_001317428.1
WBP2XM_047435712.1 linkc.580A>G p.Thr194Ala missense_variant Exon 6 of 8 XP_047291668.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WBP2ENST00000254806.8 linkc.646A>G p.Thr216Ala missense_variant Exon 6 of 8 1 NM_012478.4 ENSP00000254806.3 Q969T9-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
1439478
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
714742
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Dec 02, 2024
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.646A>G (p.T216A) alteration is located in exon 6 (coding exon 6) of the WBP2 gene. This alteration results from a A to G substitution at nucleotide position 646, causing the threonine (T) at amino acid position 216 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.16
T
BayesDel_noAF
Benign
-0.47
CADD
Benign
22
DANN
Uncertain
0.97
DEOGEN2
Benign
0.032
T;T;T;T;.;.;.
Eigen
Benign
-0.0094
Eigen_PC
Benign
0.071
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.78
T;T;T;.;T;T;T
M_CAP
Benign
0.023
T
MetaRNN
Benign
0.19
T;T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.4
L;.;.;L;.;.;.
PrimateAI
Uncertain
0.63
T
PROVEAN
Benign
-0.46
N;.;.;.;.;N;.
REVEL
Benign
0.096
Sift
Benign
0.42
T;.;.;.;.;T;.
Sift4G
Benign
1.0
T;T;T;T;T;T;.
Polyphen
0.61
P;.;.;P;.;.;.
Vest4
0.61
MutPred
0.27
Loss of glycosylation at T216 (P = 6e-04);Loss of glycosylation at T216 (P = 6e-04);.;Loss of glycosylation at T216 (P = 6e-04);.;.;.;
MVP
0.56
MPC
0.39
ClinPred
0.66
D
GERP RS
3.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.10
gMVP
0.55

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr17-73843577; API